Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia

por Khamis, Faryal, Al Naabi, Hanan, Al Lawati, Adil, Ambusaidi, Zaiyana, Al Sharji, Mariam, Al Barwani, Umkulthum, Pandak, Nenad, Al Balushi, Zakariya, Al Bahrani, Maher, Al Salmi, Issa, Al-Zakwani, Ibrahim
Publicado 2021